Acta biomaterialia

Turning human stem cells into blood vessel cells using ETV2 mRNA delivered by special lipid nanoparticles

Updated

Abstract

Transfection efficiencies exceeding 97% were achieved using ionizable lipid nanoparticles to deliver mRNA encoding the ETV2 transcription factor to human pluripotent stem cells.

  • Endothelial cells were generated with average purities greater than 90%, indicated by the expression of endothelial markers Pecam-1 (CD31) and VE-Cadherin (CD144).
  • The efficiency of forward programming was influenced by culture parameters such as initial seeding density, mRNA dosage, and time after transfection.
  • iLNP-ETV2-derived endothelial cells demonstrated key functional behaviors, including angiogenic network formation, uptake of acetylated low-density lipoprotein, and responsiveness to inflammatory cytokines.
  • This method offers a non-genome-integrating strategy for converting human pluripotent stem cells into endothelial cells, which may enhance applications in tissue engineering and disease modeling.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free